DigestRedComo funciona
Red
/
Empresas
Ba
No verificado

Basilea Pharmaceutica AG, Allschwil

Sobre qué escribimos

Anuncios brevesBiotecnologíaFinanzasGestión empresarial/Administración de EmpresasPolítica Internacional

20 Comunicados de prensa

Ver todos los comunicados de prensa
03/11/2025
Biotecnología
Anuncios breves
Política Internacional
Strong Cresemba® (isavuconazole) sales performance in Europe triggers USD 30 million milestone payment to Basilea
Fuente
Basilea Pharmaceutica AG, Allschwil
Editor
GLOBENEWSWIRE
1.00
0
24/09/2025
Biotecnología
Anuncios breves
Política Internacional
Basilea awarded BARDA contract for the development of novel oral phase 3-ready antibiotic ceftibuten-ledaborbactam
Fuente
Basilea Pharmaceutica AG, Allschwil
Editor
GLOBENEWSWIRE
1.00
0
15/09/2025
Biotecnología
Anuncios breves
Política Internacional
Basilea receives USD 25 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
Fuente
Basilea Pharmaceutica AG, Allschwil
Editor
GLOBENEWSWIRE
1.00
0
18/08/2025
Biotecnología
Anuncios breves
Política Internacional
Basilea on track with strong 2025 half-year results
Fuente
Basilea Pharmaceutica AG, Allschwil
Editor
GLOBENEWSWIRE
1.00
0
13/08/2025
Biotecnología
Anuncios breves
Política Internacional
Basilea announces in-licensing of a novel clinical phase 3-ready oral antibiotic
Fuente
Basilea Pharmaceutica AG, Allschwil
Editor
GLOBENEWSWIRE
1.00
0
28/07/2025
Biotecnología
Anuncios breves
Basilea initiates phase 3 study with antifungal fosmanogepix in invasive mold infections
Fuente
Basilea Pharmaceutica AG, Allschwil
Editor
GLOBENEWSWIRE
1.00
0
07/07/2025
Biotecnología
Anuncios breves
Política Internacional
Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
Fuente
Basilea Pharmaceutica AG, Allschwil
Editor
GLOBENEWSWIRE
1.00
0
04/06/2025
Biotecnología
Anuncios breves
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers further milestone payment to Basilea
Fuente
Basilea Pharmaceutica AG, Allschwil
Editor
GLOBENEWSWIRE
1.00
0
19/05/2025
Biotecnología
Anuncios breves
Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States
Fuente
Basilea Pharmaceutica AG, Allschwil
Editor
GLOBENEWSWIRE
1.00
0
23/04/2025
Biotecnología
Anuncios breves
Strong sales for Cresemba® (isavuconazole) in Japan trigger second milestone payment from Asahi Kasei Pharma to Basilea
Fuente
Basilea Pharmaceutica AG, Allschwil
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0